Price (delayed)
$5.39
Market cap
$26.81M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.49
Enterprise value
$39.1M
Calyxt, based in Roseville, Minnesota, is a technology company with a mission to deliver plant-based innovations for a better world. Founded in 2010, Calyxt uses its proprietary TALEN® gene editing
There are no recent dividends present for CLXT.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.